Trials / Not Yet Recruiting
Not Yet RecruitingNCT07331454
Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer
Robot-Assisted Versus Laparoscopy-Assisted Gastrectomy in Patients With cT4a Gastric Cancer: A Multicenter, Randomized Controlled, Phase III Study
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 335 (estimated)
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this multicenter, randomized, phase III clinical trial is to test whether robot-assisted radical gastrectomy improves 3-year recurrence-free survival versus laparoscopy-assisted radical gastrectomy in adults aged 18-80 years with previously untreated, resectable cT4a gastric adenocarcinoma and non-bulky lymph nodes; the main questions are whether the robotic approach confers superior RFS and maintains equivalent peri-operative safety (Clavien-Dindo ≥ II complications) and better secondary oncologic outcomes, and participants will be randomized 1:1 to undergo standardized D2 resection via robotic or laparoscopic technique and followed for 5 years with scheduled recurrence, survival, and quality-of-life assessments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Robotic Gastrectomy | Radical gastrectomy (distal or total) performed with the da Vinci robotic system, including standardized D2 lymph-node dissection, aiming for R0 resection. All operative steps (lymph-node dissection, vessel ligation, digestive reconstruction) are completed with robotic instrumentation under 3-D high-definition vision and tremor-filtered wristed instruments. |
| PROCEDURE | Laparoscopic Gastrectomy | Radical gastrectomy procedure (distal or total) performed with conventional laparoscopic instruments, including the same mandatory D2 lymph-node dissection and R0 resection criteria. |
Timeline
- Start date
- 2026-02-01
- Primary completion
- 2030-12-31
- Completion
- 2031-12-31
- First posted
- 2026-01-12
- Last updated
- 2026-01-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07331454. Inclusion in this directory is not an endorsement.